• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从大鼠脾脏胞质溶胶中纯化和鉴定一种O-连接N-乙酰葡糖胺选择性N-乙酰-β-D-氨基葡萄糖苷酶

Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

作者信息

Dong D L, Hart G W

机构信息

Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

出版信息

J Biol Chem. 1994 Jul 29;269(30):19321-30.

PMID:8034696
Abstract

Glycosylation of nuclear and cytoplasmic proteins by O-linked N-acetylglucosamine (O-GlcNAc) monosaccharides is an abundant, ubiquitous, and transient post-translational modification. To characterize enzymes involved in removal of these sugars, a neutral and cytoplasmic N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) with strong selectivity for O-GlcNAc-synthetic glycopeptides has been purified over 22,000-fold from rat spleen homogenate. The purified O-GlcNAcase has two major polypeptides of apparent M(r) = 54,000 (alpha subunit) and M(r) = 51,000 (beta subunit). Enzyme activity sediments at M(r) = 106,000 on sucrose gradients, indicating that the native O-GlcNAcase is an alpha beta heterodimer. The O-GlcNAcase also shows substantially stronger relative activity against O-GlcNAc-synthetic glycopeptides than other hexosaminidases. Unlike acidic lysosomal hexosaminidases, O-GlcNAcase is not inhibited by GalNAc or its analogs, has no other detectable glycosidase activities, and does not cross-react with antibodies against acidic hexosaminidases. Subcellular fractionation and latency studies demonstrate the cytoplasmic and nucleoplasmic localization of the enzyme and its ubiquitous presence in tissues. These studies suggest that O-GlcNAcase is involved in the regulated removal of O-GlcNAc from O-GlcNAc-bearing glycoproteins in the nucleoplasmic and cytoplasmic compartments of cells.

摘要

由O-连接的N-乙酰葡糖胺(O-GlcNAc)单糖对核蛋白和胞质蛋白进行的糖基化是一种丰富、普遍且短暂的翻译后修饰。为了鉴定参与去除这些糖类的酶,已从大鼠脾脏匀浆中纯化出一种对O-GlcNAc合成糖肽具有强选择性的中性胞质N-乙酰-β-D-葡糖胺酶(O-GlcNAcase),纯化倍数超过22000倍。纯化的O-GlcNAcase有两条主要多肽链,表观分子量分别为54000(α亚基)和51000(β亚基)。酶活性在蔗糖梯度上沉降于分子量为106000处,表明天然的O-GlcNAcase是一种αβ异二聚体。与其他己糖胺酶相比,O-GlcNAcase对O-GlcNAc合成糖肽也表现出显著更强的相对活性。与酸性溶酶体己糖胺酶不同,O-GlcNAcase不受GalNAc或其类似物的抑制,没有其他可检测到的糖苷酶活性,并且不与抗酸性己糖胺酶的抗体发生交叉反应。亚细胞分级分离和潜伏性研究证明了该酶在细胞质和核质中的定位以及它在组织中的普遍存在。这些研究表明,O-GlcNAcase参与了在细胞核质和细胞质区室中从含O-GlcNAc的糖蛋白上有调控地去除O-GlcNAc的过程。

相似文献

1
Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.从大鼠脾脏胞质溶胶中纯化和鉴定一种O-连接N-乙酰葡糖胺选择性N-乙酰-β-D-氨基葡萄糖苷酶
J Biol Chem. 1994 Jul 29;269(30):19321-30.
2
Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.细胞核和细胞质蛋白的动态O-糖基化:人脑中性细胞质β-N-乙酰氨基葡萄糖苷酶的克隆与特性分析
J Biol Chem. 2001 Mar 30;276(13):9838-45. doi: 10.1074/jbc.M010420200. Epub 2001 Jan 8.
3
Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.细胞核和细胞质蛋白的动态O-糖基化:核质β-N-乙酰氨基葡萄糖苷酶O-连接N-乙酰葡糖胺酶的进一步表征
J Biol Chem. 2002 Jan 18;277(3):1755-61. doi: 10.1074/jbc.m109656200.
4
Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate.使用荧光GlcNAc底物对O-连接的N-乙酰葡糖胺酶同工型进行酶学表征。
Carbohydr Res. 2006 Jun 12;341(8):971-82. doi: 10.1016/j.carres.2006.03.004. Epub 2006 Apr 11.
5
O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.O-连接的N-乙酰葡糖胺酶采用底物辅助催化:动力学分析及高选择性机制启发型抑制剂的开发。
J Biol Chem. 2005 Jul 8;280(27):25313-22. doi: 10.1074/jbc.M413819200. Epub 2005 Mar 28.
6
The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase.链脲佐菌素致糖尿病作用的潜在机制:抑制胰腺β细胞O-连接N-乙酰葡糖胺选择性N-乙酰-β-D-氨基葡萄糖苷酶。
Biochem J. 2001 May 15;356(Pt 1):31-41. doi: 10.1042/0264-6021:3560031.
7
Endo-N-acetyl-beta-D-glucosaminidase activity in rat liver. Studies on substrate specificity, enzyme inhibition, subcellular localization and partial purification.大鼠肝脏中的内切-N-乙酰-β-D-氨基葡萄糖苷酶活性。底物特异性、酶抑制、亚细胞定位及部分纯化的研究。
Biochem J. 1985 Jul 15;229(2):379-85. doi: 10.1042/bj2290379.
8
A di-N-acetylchitobiase activity is involved in the lysosomal catabolism of asparagine-linked glycoproteins in rat liver.二-N-乙酰壳二糖酶活性参与大鼠肝脏中天冬酰胺连接糖蛋白的溶酶体分解代谢。
J Biol Chem. 1986 May 5;261(13):5803-9.
9
Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins.原发性乳腺癌中N-乙酰-β-葡萄糖苷酶活性增加与含N-乙酰葡萄糖胺的蛋白质减少相对应。
Biochim Biophys Acta. 2001 Sep 28;1537(2):147-57. doi: 10.1016/s0925-4439(01)00067-9.
10
Purification of a chitooligosaccharidolytic beta-N-acetylglucosaminidase from Bombyx mori larvae during metamorphosis and the nucleotide sequence of its cDNA.家蚕幼虫变态期几丁质寡糖分解性β-N-乙酰氨基葡萄糖苷酶的纯化及其cDNA的核苷酸序列
Biosci Biotechnol Biochem. 1995 Feb;59(2):219-25. doi: 10.1271/bbb.59.219.

引用本文的文献

1
O‑GlcNAcylation as an emerging molecular target for cholangiocarcinoma therapy (Review).O-连接的N-乙酰葡糖胺化作为胆管癌治疗的新兴分子靶点(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8952. Epub 2025 Jul 19.
2
O-GlcNAcylation of the intellectual disability protein DDX3X exerts proteostatic cell cycle control.智力残疾蛋白DDX3X的O-连接N-乙酰葡糖胺化发挥蛋白质稳态细胞周期调控作用。
Open Biol. 2025 Jan;15(7):250064. doi: 10.1098/rsob.250064. Epub 2025 Jul 2.
3
Post translational modification regulation of transcription factors governing pancreatic β-cell identity and functional mass.
调控胰腺β细胞特性和功能量的转录因子的翻译后修饰调节
Front Endocrinol (Lausanne). 2025 Mar 11;16:1562646. doi: 10.3389/fendo.2025.1562646. eCollection 2025.
4
Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications.脑O-连接N-乙酰葡糖胺化:连接生理功能、疾病机制与治疗应用
Mol Psychiatry. 2025 Jun;30(6):2754-2772. doi: 10.1038/s41380-025-02943-z. Epub 2025 Mar 3.
5
Biological function and mechanism of NAT10 in cancer.NAT10在癌症中的生物学功能及机制
Cancer Innov. 2025 Jan 14;4(1):e154. doi: 10.1002/cai2.154. eCollection 2025 Feb.
6
Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants.利用O-连接的N-乙酰葡糖胺(O-GlcNAc)动态失衡来筛选O-GlcNAc转移酶导致智力残疾的变异体。
Stem Cell Reports. 2025 Jan 14;20(1):102380. doi: 10.1016/j.stemcr.2024.11.010. Epub 2024 Dec 19.
7
Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins.超深度 O-GlcNAc 蛋白质组学揭示了蛋白质酪氨酸残基上广泛的 O-GlcNAc 化。
Proc Natl Acad Sci U S A. 2024 Nov 19;121(47):e2409501121. doi: 10.1073/pnas.2409501121. Epub 2024 Nov 12.
8
GFPT2: A novel biomarker in mesothelioma for diagnosis and prognosis and its molecular mechanism in malignant progression.GFPT2:一种用于间皮瘤诊断和预后的新型生物标志物及其在恶性进展中的分子机制。
Br J Cancer. 2024 Nov;131(9):1529-1542. doi: 10.1038/s41416-024-02830-4. Epub 2024 Sep 24.
9
O-GlcNAc informatics: advances and trends.O-连接的N-乙酰葡糖胺信息学:进展与趋势
Anal Bioanal Chem. 2025 Feb;417(5):895-905. doi: 10.1007/s00216-024-05531-2. Epub 2024 Sep 18.
10
O-linked β-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy.O-连接的β-N-乙酰葡糖胺(O-GlcNAc)修饰:糖尿病肾病新出现的发病机制及治疗靶点
Diabet Med. 2025 Feb;42(2):e15436. doi: 10.1111/dme.15436. Epub 2024 Sep 16.